Symfi

Mylan Patient Assistance Program Patient Guide: How to Get Symfi at Low or No Cost

About This Program

Mylan's patient assistance program is designed to help eligible patients access Symfi (efavirenz/lamivudine/tenofovir disoproxil fumarate) at no cost or reduced cost. Symfi is a complete HIV treatment regimen approved by the FDA for adults and children weighing at least 88 pounds (40 kg). As a single-tablet combination, Symfi should not be used with other HIV medicines.

Who Qualifies for This Program?

To be eligible for Mylan's patient assistance program for Symfi, you must meet the following criteria:

Citizenship and Residency

• You must be a U.S. citizen or legal resident
• You must reside in the United States

Insurance Status

• You must have no prescription drug coverage, or your insurance does not cover Symfi
• You cannot have access to the medication through your current insurance plan

Financial Requirements

• Your household income must fall at or below 200% of the Federal Poverty Level
• This income threshold applies regardless of family size

Medical Requirements

• You must have a medically appropriate diagnosis of HIV-1 infection
• You must be under the care of a licensed healthcare provider who has prescribed Symfi

Income Eligibility Breakdown

The following table shows approximate 2026 income limits at 200% of the Federal Poverty Level:

Note: These figures are approximate and based on 2026 federal poverty guidelines. Contact the program directly for exact current limits.

Insurance Requirements

You are eligible for this program if:

• You have no prescription drug coverage whatsoever, OR
• Your current insurance plan does not cover Symfi, OR
• Your insurance coverage is insufficient to make the medication affordable

If you have Medicare, Medicaid, or other government insurance, you may still qualify if Symfi is not covered under your specific plan or if you cannot afford your out-of-pocket costs.

How to Apply: Step-by-Step Process

Step 1: Gather Required Documentation

Before starting your application, collect the following:

• Proof of income (recent tax return, pay stubs, or benefit statements)
• Proof of U.S. citizenship or legal residency
• Proof of lack of prescription drug insurance (insurance denial letter or statement)
• A valid prescription for Symfi from your healthcare provider
• Your healthcare provider's contact information

Step 2: Contact the Program

Call Mylan's patient assistance program to request an application. Your healthcare provider can also help initiate the process.

Step 3: Complete the Application

You will receive an application form that requires:

• Your personal and household information
• Financial information and proof of income
• Insurance status documentation
• Your signature and your healthcare provider's signature

Your healthcare provider must complete their section of the application and attach a valid prescription for Symfi.

Step 4: Submit Your Application

Submit your completed application along with all required documentation. Applications can typically be submitted by mail or fax. Your healthcare provider's office may assist with submission.

Step 5: Await Approval

The program will review your application and contact you with a decision. Once approved, the medication will be shipped directly to your pharmacy or home address.

Timeline and Medication Delivery

Processing Time

• Applications are typically processed within 5-10 business days, though this may vary
• Contact the program for specific timeline information

Medication Supply

• Approved patients generally receive up to a 90-day supply of Symfi
• Refills may be available through reapplication or automatic renewal processes

Delivery Method

• Symfi is typically shipped directly to your pharmacy or home address
• Specialty pharmacy services may be used to coordinate delivery

What If Your Application Is Denied?

If your application is denied, you have several options:

1. Request clarification: Contact the program to understand why you were denied and whether you can provide additional documentation
2. Reapply: If your circumstances change (income decreases, insurance coverage ends), you may reapply
3. Explore alternatives: Ask your healthcare provider about other patient assistance programs, state AIDS Drug Assistance Programs (ADAP), or other financial resources
4. Contact advocacy organizations: HIV/AIDS advocacy groups may help connect you with additional resources

Reauthorization and Refills

Most patient assistance programs require annual reauthorization. You will likely need to:

• Reapply each year with updated financial documentation
• Confirm your continued eligibility
• Provide an updated prescription from your healthcare provider

The program will notify you when reauthorization is required.

About Symfi

What is Symfi? Symfi is a complete HIV treatment regimen containing three active ingredients: efavirenz (400 mg), lamivudine (300 mg), and tenofovir disoproxil fumarate (300 mg). It is taken as a single tablet once daily.

Why Symfi? Symfi Lo represents a significant advancement in HIV treatment, featuring a reduced dose of efavirenz (one-third less than the original 1998 formulation). This lower dose may reduce side effects while maintaining effectiveness. Mylan launched Symfi at a significant discount to help address the high cost of HIV treatment in the United States.

Important: Symfi is a complete regimen and should not be used with other HIV medicines. Always take it exactly as prescribed by your healthcare provider.

Disclaimer

This guide provides general information about Mylan's patient assistance program for Symfi. Program details, income limits, and eligibility requirements may change. For the most current and accurate information, contact Mylan's patient assistance program directly or speak with your healthcare provider. This guide is not a guarantee of eligibility or approval. Each application is reviewed individually based on current program guidelines and your specific circumstances.